The Experts Are Hot on the Case! Solving PN/ILE Dilemmas in Adult and Pediatric Patients (CE/CME Symposium)
To register for the in-person symposium, please click Register/Take Course.
To register for virtual attendance, please click here.
Monday, March 4, 2024
5:30 AM – 6:00 AM ET Registration and Breakfast
6:00 AM – 7:30 AM ET CE/CME Symposium
Tampa Marriott Water Street
Florida Ballroom, Salons V and VI
505 Water Street
This educational activity is intended for dietitians, pharmacists, nurses, and physicians engaged in the care of adult and pediatric/neonatal patients requiring parenteral nutrition.
After completing this activity, participants will be better able to:
- Select the appropriate dose of various intravenous lipid emulsions to prevent essential fatty acid deficiency in adult and pediatric patients
- Summarize recent guidelines for provision of intravenous lipid emulsions in preterm infants
- Illustrate appropriate use of intravenous lipid emulsions in pediatric/neonatal patients at risk for intestinal failure–associated liver disease
- Illustrate appropriate use of intravenous lipid emulsions in hospital and home adult patients with comorbidities
Kris M. Mogensen, MS, RD-AP, LDN, CNSC (Chair)
Kara Calkins, MD
Ryan T. Hurt, MD, PhD
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Kara Calkins, MD, is a consultant for Baxter and Fresenius Kabi USA; and is a contracted researcher for Mead Johnson & Company, LLC.
Ryan T. Hurt, MD, PhD, is a consultant for Nestlé.
Kris M. Mogensen, MS, RD-AP, is an advisory board member of Baxter*.
* The financial relationship existed during the past 24 months but has now ended
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners and managers have no relevant commercial relationships to disclose.
Learners must complete an evaluation form to receive a certificate of completion. You must attend the entire symposium as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Dietitians (CDR) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 CPEUs.
For Pharmacists and Nurses
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 knowledge-based CPE contact hours.
Live UAN: JA4008163-9999-24-045-L99-P | UAN JA4008163-9999-24-045-L99-T
The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 ANCC contact hours.
ACCME Accreditation Statement
MedEdicus LLC is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Fresenius Kabi USA.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at email@example.com.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or Fresenius Kabi USA.
This CE/CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 316a
- 1.50 ACPE
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDR
- 1.50 Participation